| Trial ID: | L7156 |
| Source ID: | NCT01565733
|
| Associated Drug: |
Biphasic Insulin Aspart 30
|
| Title: |
Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: biphasic insulin aspart 30
|
| Outcome Measures: |
Primary: Frequency of severe hypoglycaemic episodes | Secondary: Number of severe hypoglycaemic episodes|Number of mild hypoglycaemic episodes|Postprandial glucose concentration after breakfast, lunch, and dinner|Average fasting glucose concentration after waking and before main meals|Average plasma glucose level at bedtime and at night
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
2223
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2007-01
|
| Completion Date: |
2007-07
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-31
|
| Locations: |
Novo Nordisk Investigational Site, Warszawa, PL-02-274, Poland
|
| URL: |
https://clinicaltrials.gov/show/NCT01565733
|
